A Disrupted Market Reveals Which Pharmacies Were Ready

Drug Topics ran an editorial in its July/August issue that every independent pharmacy owner should read carefully. The title is "Facing Reimbursement Pressure, Pharmacy Answers With Clinical Value," and the headline implies pressure rather than triumph.

The article describes what's happening across long-term care pharmacy right now. Reimbursement changes tied to the Inflation Reduction Act are pushing more than 80% of long-term care pharmacies to cut services in 2026, and the projection is that more than 1.6 million vulnerable seniors could be affected, disproportionately in rural communities and disproportionately in the markets where independent community pharmacy is often the last pharmacy standing.

Then Drug Topics asks the question directly. As closed-door long-term care operators retreat, what role can community and independent pharmacists play in closing the gap?

That's the right question. Most independent pharmacy owners will read it as a clinical question, and it's also a patient attraction question. The distinction matters.

Disruption Puts Patients in Motion

Here's the full picture of what's moving right now. Long-term care pharmacies are cutting services. GLP-1 coverage is becoming unstable as employers reduce benefits and coverage decisions shift faster than patients can follow. Retail chains keep closing stores in markets where patients had limited options to begin with.

All of that creates motion. Patients who were passive in their pharmacy relationship are being pushed into active decisions. Some are looking for a new pharmacy because theirs no longer exists, some need a pharmacy that can navigate the medication access issues their insurance plan just created, and some are elderly patients who depended on services that are being reduced and are trying to figure out what comes next. They're all making decisions they didn't expect to be making, and those decisions aren't slow.

In a normal market, most patients don't think deliberately about their pharmacy. They fill, they leave, they come back. The relationship is transactional and mostly unexamined, and there's no urgency in it. In a disrupted market, the urgency shows up, patients start making active choices, and that's the window independent pharmacy can walk through.

The Trap Is Waiting

The trap most owners fall into during market disruption is the same one they fall into during normal conditions. They wait. They assume clinical quality speaks for itself, that displaced patients will find their way to the obvious choice, and that being good is enough to be chosen.

But displacement doesn't come with a map. When a patient loses their pharmacy service, they don't sit down and evaluate every option systematically. They reach for a name they've heard somewhere, or they choose whatever is fastest and nearest with no particular reason at all. The pharmacy that wins displaced patients is usually the most familiar one in the market rather than the most capable one, and familiarity gets built by showing up in the community over months.

That's the patient attraction argument, and it has nothing to do with the advertising budget.

The Clinical Case Is Real

The Drug Topics editorial describes what's at stake clinically, and that case is strong. Pharmacist-led medication therapy management for patients managing diabetes, cardiovascular disease, and hypertension has been shown across multiple studies to improve clinical outcomes and reduce total health care costs. These aren't rare patients. They're the majority of patients at every independent pharmacy in the country. A pharmacy with point-of-care testing, medication synchronization, and clinical follow-up protocols has something a chain operating under margin pressure can't offer and mail order can't replicate.

But clinical capability only attracts patients if the community knows it exists. That's the gap.

What the Prepared Owner Already Built

The owner who's been doing the attraction work has been present in small, consistent ways for months: a monthly newsletter that names specific services and teaches something useful, a transfer process simple enough that switching is easy for a patient already in motion, and a referral prompt that gives loyal patients the words to describe what their pharmacy does when a neighbor or a family member asks.

None of that is complicated. But it has to exist before the patient starts looking, because the decision window is short once a patient is in motion. They don't schedule research time or compare every option. They make a fast decision with what's already in their head. The pharmacy that's been present, visible, and specific about what it does gets considered. The pharmacy that's been doing excellent work without telling anyone doesn't.

The Growth Argument Is One Step Further

Drug Topics is right that pharmacies answer reimbursement pressure with clinical value. That's the clinical argument. The growth argument goes one step further, because clinical value attracts patients only when it's communicated. Clinical value that stays inside the four walls of a pharmacy is a service. Clinical value that reaches the community is an attraction system.

The independent pharmacy that grows through this disruption will be the one that was already on the list when the patient started looking.

A disrupted market does not choose winners. It reveals which pharmacies were ready.

If you can't name what your community has actually heard from your pharmacy in the last ninety days, that's worth knowing before the next disruption in your market puts patients in motion. The Independent Pharmacy Growth Index shows you where your growth system is holding and where it's leaking, across attraction, referrals, retention, and the gap between what your pharmacy does clinically and what your community knows about it. It takes a few minutes, and it tells you the truth.

Mike Hodges

Founder, Pharmacy Breakthroughs Mastermind

Former independent pharmacy owner